SYNTHESIS OF CHIRAL CIS-3-HYDROXYAZETIDINES
803
MgSO4, then solvent was removed to give a crude Calcd for C17H18ClNO: C, 71.0; H, 6.30; N, 4.87. Found: C,
mixture, 1-(10-phenylethyl)-2-phenyl-3-hydroxyazetidine (L1a 70.9; H, 6.39; N, 4.64.
and L1b), which was further purified by chromatography
(hexane/ethyl acetate 5 5/1) to afford pure compounds
(10R,2R,3R)-1-(10-phenylethyl)-2-(3-chlorophenyl)-3-
(10R,2R,3R)-1-(10-phenylethyl)-2-phenyl-3-hydroxyazetidine
hydroxyazetidine (L3a)
(L1a; 2.18 g, 43%) and (10R,2S,3S)-1-(10-phenylethyl)-2-
phenyl-3-hydroxyazetidine (L1b; 1.06 g, 21%), total yield:
3.24 g, 64%.
Colorless crystals, mp 89–918C; [a]2D0 5 2200.2 (c 0.44,
1
CH2Cl2); H NMR (500 MHz, CDCl3): d 1.35 (d, J 5 6.5
Hz, 3H), 1.65 (br, s, 1H), 3.32 (m, 1H), 3.46 (q, J 5 6.2 Hz,
1H), 3.50 (d, J 5 8.2 Hz, 1H), 4.20 (d, J 5 5.2 Hz, 1H), 4.43
(q, J 5 5.6 Hz, 1H), 7.03–7.10 (m, 6H), 7.18–7.21 (m, 3H)
ppm; 13C NMR (125 MHz, CDCl3): d 19.5, 58.8, 66.1, 67.1,
71.7, 126.0, 127.1, 127.3, 127.8, 128.1, 128.3, 128.9, 133.7,
139.3, 141.9 ppm; IR (KBr): 3437, 2975 1601 cm21; MS
(EI): m/z 287 (M1); Anal. Calcd for C17H18ClNO: C, 71.0;
H, 6.30; N, 4.87. Found: C, 70.9; H, 6.45; N, 4.83.
(10R,2R,3R)-1-(10-phenylethyl)-2-phenyl-3-
hydroxyazetidine (L1a)
Colorless crystals, mp 136–1388C; [a]2D0 5 2188.0 (c
1
0.67, CH2Cl2); H NMR (300 MHz, CDCl3): d 1.30 (d, J 5
6.6 Hz, 3H), 1.71 (d, J 5 5.7 Hz, 1H), 3.29 (m, 1H), 3.47
(m, 2H), 4.23 (d, J 5 6.0 Hz, 1H), 4.38 (q, J 5 5.7 Hz, 1H),
6.99–7.07 (m, 3H), 7.09–7.26 (m, 7H) ppm; 13C NMR (75
MHz, CDCl3): d 19.5, 58.6, 66.0, 66.7, 72.0, 127.0, 127.1,
127.6, 127.7, 128.0, 136.9, 142.1 ppm; IR (KBr): 3464, 2963,
1602 cm21; MS (EI): m/z 253 (M1); Anal. Calcd for
C17H19NO: C, 80.6; H, 7.56; N, 5.53. Found: C, 80.3; H,
7.50; N, 5.43.
(10R,2S,3S)-1-(10-phenylethyl)-2-(3-chlorophenyl)-3-
hydroxyazetidine (L3b)
Colorless crystals, mp 64–668C; [a]2D0 5 193.2 (c 0.31,
1
CH2Cl2); H NMR (500 MHz, CDCl3): d 1.05 (d, J 5 6.5
(10R,2S,3S)-1-(10-phenylethyl)-2-phenyl-3-
hydroxyazetidine (L1b)
Hz, 3H), 1.61 (d, J 5 6.5 Hz, 1H), 3.05 (m, 1H), 3.15 (d, J
5 9.0 Hz, 1H), 3.52 (q, J 5 6.5 Hz, 1H), 4.36 (d, J 5 6.0
Hz, 1H), 4.43 (q, J 5 6.0 Hz, 1H), 7.28–7.50 (m, 8H), 7.64
(s, 1H) ppm; 13C NMR (125 MHz, CDCl3): d 22.7, 59.0,
65.9, 67.8, 71.8, 126.0, 127.1, 127.2, 127.8, 128.1, 128.4,
129.6, 134.5, 140.9, 143.4 ppm; IR (KBr): 3423, 2966 1600
cm21; MS (EI): m/z 286 (M1 2 1); Anal. Calcd for
C17H18ClNO: C, 71.0; H, 6.30; N, 4.87. Found: C, 70.9; H,
6.64; N, 4.81.
Colorless crystals, mp 108–1108C; [a]2D0 5 1116.3 (c
1
0.32, CH2Cl2); H NMR (400 MHz, CDCl3): d 1.06 (d, J 5
6.4 Hz, 3H), 1.68 (s, 1H), 3.04 (m, 1H), 3.16 (d, J 5 8.8 Hz,
1H), 3.53 (q, J 5 6.4 Hz, 1H), 4.42 (s, 2H), 7.27–7.47 (m,
8H), 7.63 (d, J 5 7.6 Hz, 2H) ppm; 13C NMR (100 MHz,
CDCl3): d 22.9, 59.0, 65.8, 67.9, 72.2, 127.0, 127.2, 127.6,
127.8, 128.3, 128.4, 138.4, 143.7 ppm; IR (KBr): 3412, 2973,
1605 cm21; MS (EI): m/z 253 (M1); Anal. Calcd for
C17H19NO: C, 80.6; H, 7.56; N, 5.53. Found: C, 80.5; H,
7.53; N, 5.53.
(10R,2R,3R)-1-(10-phenylethyl)-2-(4-chlorophenyl)-3-
hydroxyazetidine (L4a)
Colorless crystals, mp 105–1078C; [a]2D0 5 2204.2 (c
0.43, CH2Cl2); H NMR (500 MHz, CDCl3): d 1.34 (d, J 5
(10R,2R,3R)-1-(10-phenylethyl)-2-(2-chlorophenyl)-3-
hydroxyazetidine (L2a)
1
6.5 Hz, 3H), 1.63 (br, S, 1H), 3.33 (m, 1H), 3.46 (d, J 5 6.0
Hz, 1H), 3.51 (d, J 5 8.5 Hz, 1H), 4.20 (d, J 5 5.5 Hz, 1H),
4.42 (d, J 5 5.5 Hz, 1H), 7.04–7.08 (m, 3H), 7.12–7.17 (m,
6H) ppm; 13C NMR (125 MHz, CDCl3): d 19.7, 58.9, 66.0,
67.1, 71.6, 127.2, 127.8, 127.9, 128.0, 129.5, 132.7, 135.7,
142.0. IR (KBr): 3461, 2943, 1598 cm21; MS (EI): m/z 286
(M1 2 1); Anal. Calcd for C17H18ClNO: C, 71.0; H, 6.30;
N, 4.87; Found: C, 70.9; H, 6.66; N, 4.79.
Colorless crystals, mp 50–528C; [a]2D0 5 2112.8 (c 0.19,
CH2Cl2); H NMR (500 MHz, CDCl3): d 1.40 (d, J 5 5.5
1
Hz, 3H), 1.52 (d, J 5 5.0 Hz, 1H), 3.41 (m, 1H), 3.51 (m,
2H), 4.63 (q, J 5 5.5 Hz, 1H), 4.69 (br, s, 1H), 7.05–7.16
(m, 5H), 7.28 (m, 3H), 7.49 (br, s, 1H) ppm; 13C NMR
(125 MHz, CDCl3): d 18.6, 58.6, 65.3, 66.4, 69.2, 125.9,
127.2, 127.9, 128.0, 128.4, 130.7, 131.7, 134.6, 142.0 ppm;
IR (KBr): 3438, 2970, 1630 cm21; MS (EI): m/z 286 (M1
–
1); Anal. Calcd for C17H18ClNO: C, 71.0; H, 6.30; N, 4.87.
Found: C, 70.9; H, 6.60; N, 4.79.
(10R,2S,3S)-1-(10-phenylethyl)-2-(4-chlorophenyl)-3-
hydroxyazetidine (L4b)
(10R,2S,3S)-1-(10-phenylethyl)-2-(2-chlorophenyl)-3-
hydroxyazetidine (L2b)
Colorless crystals, mp 110–1128C; [a]2D0 5 199.7 (c
1
0.30, CH2Cl2); H NMR (500 MHz, CDCl3): d 1.03 (d, J 5
Colorless crystals, mp 92–948C; [a]2D0 5 1140.4 (c 0.29, 6.5 Hz, 3H), 1.56 (d, J 5 6.5 Hz, 1H), 3.04 (m, 1H), 3.14
1
CH2Cl2); H NMR (500 MHz, CDCl3): d 1.10 (d, J 5 6.5 (d, J 5 9.0 Hz, 1H), 3.51(q, J 5 6.5 Hz, 1H), 4.36 (d, J 5
Hz, 3H), 1.54 (d, J 5 6.5 Hz, 1H), 3.12 (dd, J 5 9.5, 6.5 Hz, 6.0 Hz, 1H), 4.42 (q, J 5 6.0 Hz, 1H), 7.27–7.42 (m, 7H),
1H), 3.19 (d, J 5 9.5 Hz, 1H), 3.58 (q, J 5 6.5 Hz, 1H), 4.65 7.57 (d, J 5 8.0 Hz, 2H) ppm; 13C NMR (125 MHz,
(q, J 5 5.5 Hz, 1H), 4.73 (d, J 5 6.0 Hz, 1H), 7.27–7.46 (m, CDCl3): d 22.9, 59.0, 65.9, 67.9, 71.7, 127.1, 127.2, 128.4,
8H), 8.13 (d, J 5 7.0 Hz, 1H) ppm; 13C NMR (125 MHz, 128.6, 129.3, 133.4, 137.1, 143.5 ppm; IR (KBr): 3432, 2966
;
CDCl3): d 22.9, 59.3, 65.0, 68.1, 69.7, 126.6, 127.2, 127.3, cm21 MS (EI): m/z 287 (M1); Anal. Calcd for
128.4, 128.6, 129.0, 130.8, 132.0, 136.3, 143.7 ppm; IR C17H18ClNO: C, 71.0; H, 6.30; N, 4.87. Found: C, 70.9; H,
(KBr): 3442, 2965 cm21; MS (EI): m/z 286 (M1 – 1); Anal. 6.21; N, 4.75.
Chirality DOI 10.1002/chir